Medicared For All Logo

Venkatasiva Peram MD in Flint, Michigan

Home Michigan Flint

Venkatasiva Peram MD has Hematology/oncology as his primary medical specialty. Their primary office is: 5467 Hill 23 Dr in Flint, Michigan. They attended Sorry, his university is not listed and graduated in 1991 (around 33 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Venkatasiva R Peram MD Office Phone and Directions

Venkatasiva Peram MD
5467 Hill 23 Dr
Flint, Michigan 48507
810-720-0002


Patient Ratings
Please rate your experience with Venkatasiva Peram MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 810-720-0002


Enter a starting address:


Healthcare Info for Venkatasiva Peram MD

Medical School: Sorry, his university is not listed
Graduation Year: 1991
The Primary Medical Specialty for Venkatasiva Peram MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 33
PAC (PECOS ID)#: 9537132063
NPI #: 1881617702
NPI Created On: 07/25/2006
NPI Last Updated Listed as: 07/08/2007
Primary Taxonomy Code: 207RH0003X
License Number:
4301070246
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • McLaren Health Plan Community
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Telugu.


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  3. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  4. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  5. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
  6. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
  7. Infusion of chemotherapy into a vein up to 1 hour
  8. Infusion of chemotherapy into a vein
  9. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
  10. Irrigation of implanted venous access drug delivery device
  11. New patient office or other outpatient visit, typically 45 minutes
  12. New patient office or other outpatient visit, typically 60 minutes
  13. Established patient office or other outpatient visit, typically 15 minutes
  14. Established patient office or other outpatient, visit typically 25 minutes
  15. Established patient office or other outpatient, visit typically 40 minutes
  16. Initial hospital inpatient care, typically 50 minutes per day
  17. Initial hospital inpatient care, typically 70 minutes per day
  18. Subsequent hospital inpatient care, typically 15 minutes per day
  19. Subsequent hospital inpatient care, typically 25 minutes per day
  20. Subsequent hospital inpatient care, typically 35 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788781939

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12


Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788781941

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $7

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788781943

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $0

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788781945

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788781947

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05


Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788781949

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: RYBREVANT

Open Associated Drug #1: 57894-501-01


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788781951

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05


Payments Total: $38

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788781953

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781013895

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795595899

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22


Hematology/oncology Professionals in Flint

401 S Ballenger Hwy
Flint, MI
Mclaren Flint

4100 Beecher Rd
Flint, MI
Mclaren Flint

401 S Ballenger Hwy
Flint, MI
Mclaren Flint

4100 Beecher Rd
Flint, MI
Mclaren Flint

302 Kensington Ave
Flint, MI

5080 Villa Linde Pkwy
Flint, MI

Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry